Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
Top
..
c19early.org COVID-19 treatment researchSelect treatment..Select..
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

COVID-19 treatment protocol in Ukraine

$0 $500 $1,000+ COVID-19 treatment protocols average efficacy and cost Ukraine Philippines Argentina Pakistan USA Russia Bangladesh South Africa Brazil United Kingdom Iran Vietnam Turkey Italy France Spain Germany Kenya Japan India Mexico South Korea Indonesia Uganda Nigeria Ethiopia DR Congo Algeria Angola Peru Bosnia-Herzegovina New Zealand Poland Congo United Arab Emirates Sri Lanka Morocco Panama Bahrain Ghana Qatar Cameroon Dominican Republic Paraguay Ukraine favored low-cost treatments.The average efficacy of approved treatments was moderate.Low-cost non-prescription treatments improve early treatment, andprovide complementary and synergistic benefits from combined therapy. More effective More expensive c19early.org February 2025 75% 50% 25% ≤0%
$0 $500 $1,000+ C19 treatment protocols avg. efficacy/cost Ukraine Philippines Argentina Pakistan USA Russia Bangladesh South Africa Brazil United Kingdom Iran Vietnam Turkey Italy France Spain Germany Kenya Japan India Mexico South Korea Indonesia Uganda Nigeria Ethiopia DR Congo Algeria Angola Peru Israel Congo Afghanistan Sri Lanka Morocco Bahrain Ghana Qatar Cameroon Dominican Rep. Ukraine favored low-cost treatments.The average efficacy was moderate.Low-cost protocols improve early treatment,and add complementary/synergistic benefits. More effective More expensive c19early.org February 2025 75% 50% 25% ≤0%
Countries adopted very different treatment protocols for COVID-19. Some countries preferred novel high-profit treatments, while others also used many low-cost treatments. Low-cost non-prescription treatments can greatly increase treatment—especially early treatment—due to lower barriers to access, and research shows complementary and synergistic benefits with many treatments1-12.
The plot shows the average efficacy and cost of approved treatments in each country. Actual usage varied significantly from official protocols in many regions. Top countries by population are shown where space precludes showing all country names.
Acetaminophen - official - country-wide adoption
Aspirin - official - mixed usage
Bamlanivimab/etesevimab - official - country-wide adoption
Favipiravir - official - country-wide adoption
Ibuprofen - official - country-wide adoption
Ivermectin - official - mixed usage
Melatonin - official - mixed usage
Molnupiravir - official - country-wide adoption
Paxlovid - official - country-wide adoption
Quercetin - official - mixed usage
Remdesivir - official - country-wide adoption
Vitamin C - official - mixed usage
Vitamin D - official - mixed usage
Zinc - official - mixed usage
Submit updates or corrections.
References
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.
Submit